Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

ENaC as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01804777
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:55.652656+00:00
Published At
2018-05-11T00:00:00+00:00
Record Updated At
2018-05-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Proteinuria", "Hypertension", "Type II Diabetes"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-05-11"
protocolSection.identificationModule.nctId
"NCT01804777"
protocolSection.identificationModule.officialTitle
"ENaC as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Proteinuria (protocolSection.conditionsModule.conditions)
  • Hypertension (protocolSection.conditionsModule.conditions)
  • Type II Diabetes (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.